<?xml version="1.0" encoding="UTF-8"?>
<ref id="B12-vaccines-08-00306">
 <label>12.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yang</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Shim</surname>
    <given-names>S.M.</given-names>
   </name>
   <name>
    <surname>Nguyen</surname>
    <given-names>T.Q.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>E.H.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Lim</surname>
    <given-names>Y.T.</given-names>
   </name>
   <name>
    <surname>Sung</surname>
    <given-names>M.H.</given-names>
   </name>
   <name>
    <surname>Webby</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Poo</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>Poly-gamma-glutamic acid/chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of h1n1 pandemic influenza vaccine</article-title>
  <source>Sci. Rep.</source>
  <year>2017</year>
  <volume>7</volume>
  <fpage>44839</fpage>
  <pub-id pub-id-type="doi">10.1038/srep44839</pub-id>
  <?supplied-pmid 28322289?>
  <pub-id pub-id-type="pmid">28322289</pub-id>
 </element-citation>
</ref>
